Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ccl19em1/Cya
Common Name:
Ccl19-KO
Product ID:
S-KO-19837
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ccl19-KO
Strain ID
KOCMP-24047-Ccl19-B6J-VA
Gene Name
Ccl19
Product ID
S-KO-19837
Gene Alias
CKb11; ELC; Gm2023; MIP3B; Scya19; exodus-3
Background
C57BL/6JCya
NCBI ID
24047
Modification
Conventional knockout
Chromosome
4
Phenotype
MGI:1346316
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ccl19em1/Cya mice (Catalog S-KO-19837) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000102957
NCBI RefSeq
NM_011888
Target Region
Exon 2~4
Size of Effective Region
~5.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ccl19, also known as Chemokine (C-C motif) ligand 19, is a homeostatic chemokine abundantly expressed in the thymus and lymph nodes. It primarily regulates immune cell trafficking and is involved in various biological processes such as T cell activation, immune tolerance, and inflammatory responses. It acts through interaction with its cognate receptor CCR7, and the CCL19-CCR7 axis plays a crucial role in the onset of adaptive immunity, with its signaling pathways influencing viral pathogenesis, immune surveillance, and homeostasis [5].

In cancer research, Ccl19 seems to have a dual-edged role. Ccl19-producing fibroblasts promote the formation of tertiary lymphoid structures (TLSs) in colorectal cancer liver metastasis, enhancing the anti-tumor IgG response. CCL19 treatment also promotes TLS neogenesis and prevents tumor growth in mice [1]. In chimeric antigen receptor (CAR)-T cell therapy for solid tumors, engineering CAR-T cells to secrete CCL19 enhances their expansion, migration, and tumor-suppressing abilities. For example, in hepatocellular carcinoma and pancreatic carcinoma xenografts, 7×19 CAR-T cells (secreting IL-7 and CCL19) show superior tumor suppression compared to conventional CAR-T cells [2,3]. In triple-negative breast cancer, CCL19-expressing dendritic cells are associated with favorable responses to anti-PD-(L)1 immunotherapy, and Ccl19 gene ablation dampens CCR7+CD8+ T cells and tumor elimination in response to anti-PD-1 [4].

In allergic airway disease, Ccl19-deficient mice have less allergic airway inflammation, reduced airway hyper-responsiveness, and less IL-4 and IL-13 production, indicating that CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation [6]. In a mouse model of chronic hepatitis B, CCL19 overexpression leads to rapid clearance of intrahepatic HBV through increased intrahepatic CD8+ T-cell proportion and other immune-related mechanisms [7].

In conclusion, Ccl19 is a key regulator in immune-related processes. Model-based research, especially using gene-knockout mouse models in various disease areas such as cancer, allergic airway disease, and viral infection, has revealed its diverse functions. In cancer, it can either promote anti-tumor immune responses or act as a tumor-supportive factor, while in allergic airway disease it contributes to inflammation, and in HBV infection it aids in virus clearance. These findings provide valuable insights into potential therapeutic strategies targeting Ccl19 in different diseases.

References:
1. Zhang, Yifan, Liu, Guangjian, Zeng, Qianwen, Chen, Zhihang, Kuang, Ming. . CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. In Cancer cell, 42, 1370-1385.e9. doi:10.1016/j.ccell.2024.07.006. https://pubmed.ncbi.nlm.nih.gov/39137726/
2. Pang, Nengzhi, Shi, Jingxuan, Qin, Le, Li, Peng, Zhang, Zhenfeng. 2021. IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin. In Journal of hematology & oncology, 14, 118. doi:10.1186/s13045-021-01128-9. https://pubmed.ncbi.nlm.nih.gov/34325726/
3. Lu, Li-Li, Xiao, Shu-Xiu, Lin, Zhi-Yuan, Lu, Bin, Wu, Wei-Zhong. 2023. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy. In Cell biology and toxicology, 39, 3101-3119. doi:10.1007/s10565-023-09821-w. https://pubmed.ncbi.nlm.nih.gov/37853185/
4. Wu, Song-Yang, Zhang, Si-Wei, Ma, Ding, Shao, Zhi-Ming, Jiang, Yi-Zhou. 2023. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer. In Med (New York, N.Y.), 4, 373-393.e8. doi:10.1016/j.medj.2023.04.008. https://pubmed.ncbi.nlm.nih.gov/37201522/
5. Yan, Yan, Chen, Renfang, Wang, Xu, Lu, Mengji, Hu, Qinxue. 2019. CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention. In Frontiers in cell and developmental biology, 7, 212. doi:10.3389/fcell.2019.00212. https://pubmed.ncbi.nlm.nih.gov/31632965/
6. Nakano, Keiko, Whitehead, Gregory S, Lyons-Cohen, Miranda R, Cook, Donald N, Nakano, Hideki. 2023. Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation. In The Journal of allergy and clinical immunology, 153, 487-502.e9. doi:10.1016/j.jaci.2023.10.024. https://pubmed.ncbi.nlm.nih.gov/37956733/
7. Yan, Yan, Zhao, Wei, Liu, Wei, Xun, Jingna, Davgadorj, Chantsalmaa. 2021. CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance. In Journal of gastroenterology, 56, 769-785. doi:10.1007/s00535-021-01799-8. https://pubmed.ncbi.nlm.nih.gov/34218330/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest